BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37895939)

  • 1. Discovery of Novel Tryptanthrin Derivatives with Benzenesulfonamide Substituents as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease.
    Wang G; Du J; Ma J; Liu P; Xing S; Xia J; Dong S; Li Z
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Xia J; Dong S; Yang L; Wang F; Xing S; Du J; Li Z
    Bioorg Chem; 2024 Feb; 143():106980. PubMed ID: 38006789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the "hidden" multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease.
    Chen R; Li X; Chen H; Wang K; Xue T; Mi J; Ban Y; Zhu G; Zhou Y; Dong W; Tang L; Sang Z
    Eur J Med Chem; 2023 May; 251():115253. PubMed ID: 36921526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease.
    Wang M; Fang L; Liu T; Chen X; Zheng Y; Zhang Y; Chen S; Li Z
    Chem Biol Interact; 2021 Jun; 342():109489. PubMed ID: 33905740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Pan W; Wang K; Ma Q; Yu L; Yang Y; Bai P; Leng C; Xu Q; Li X; Tan Z; Liu W
    Eur J Med Chem; 2017 Apr; 130():379-392. PubMed ID: 28279845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Liu T; Chen S; Du J; Xing S; Li R; Li Z
    Eur J Med Chem; 2022 Jan; 227():113973. PubMed ID: 34752955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease.
    Karimi Askarani H; Iraji A; Rastegari A; Abbas Bukhari SN; Firuzi O; Akbarzadeh T; Saeedi M
    BMC Chem; 2020 Dec; 14(1):64. PubMed ID: 33134975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives.
    Yang A; Liu C; Zhang H; Wu J; Shen R; Kou X
    Eur J Med Chem; 2022 Apr; 233():114216. PubMed ID: 35227980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
    Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease.
    Sang Z; Wang K; Han X; Cao M; Tan Z; Liu W
    ACS Chem Neurosci; 2019 Feb; 10(2):1008-1024. PubMed ID: 30537804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease.
    Dong S; Xia J; Wang F; Yang L; Xing S; Du J; Zhang T; Li Z
    Eur J Med Chem; 2024 Jan; 264():116013. PubMed ID: 38052155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Shi J; Zhou Y; Wang K; Zhao Y; Li Q; Qiao Z; Wu A; Tan Z; Liu W
    Bioorg Chem; 2021 Feb; 107():104602. PubMed ID: 33453647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.
    Liu W; Wu L; Liu W; Tian L; Chen H; Wu Z; Wang N; Liu X; Qiu J; Feng X; Xu Z; Jiang X; Zhao Q
    Eur J Med Chem; 2022 Nov; 242():114689. PubMed ID: 36007469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.
    Rastegari A; Safavi M; Vafadarnejad F; Najafi Z; Hariri R; Bukhari SNA; Iraji A; Edraki N; Firuzi O; Saeedi M; Mahdavi M; Akbarzadeh T
    Mol Divers; 2022 Feb; 26(1):409-428. PubMed ID: 34273065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
    Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromone derivatives bearing pyridinium moiety as multi-target-directed ligands against Alzheimer's disease.
    Abdpour S; Jalili-Baleh L; Nadri H; Forootanfar H; Bukhari SNA; Ramazani A; Ebrahimi SES; Foroumadi A; Khoobi M
    Bioorg Chem; 2021 May; 110():104750. PubMed ID: 33691251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.